Si-Cong Ma
NYU Langone Health(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, PARP inhibition in cancer therapy, Lung Cancer Treatments and Mutations, Genetic factors in colorectal cancer, DNA Repair Mechanisms
Most-Cited Works
- → Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer(2020)252 cited
- → Development and Validation of a Deep Learning-Based Model Using Computed Tomography Imaging for Predicting Disease Severity of Coronavirus Disease 2019(2020)81 cited
- → Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study(2020)63 cited
- → CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy(2023)54 cited
- → Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studies(2021)41 cited
- → PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer(2022)31 cited
- → Efficacy and Treatment Strategies in Advanced Cancers with Liver Metastasis Receiving Atezolizumab Therapy(2021)26 cited
- → Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies—pharmacovigilance database analysis with real-world data validation(2023)20 cited
- → PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy(2025)19 cited
- → Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice(2022)19 cited